scholarly journals Allogeneic marrow transplantation in patients with severe systemic sclerosis: Resolution of dermal fibrosis

2006 ◽  
Vol 54 (6) ◽  
pp. 1982-1986 ◽  
Author(s):  
Richard A. Nash ◽  
Peter A. McSweeney ◽  
J. Lee Nelson ◽  
Mark Wener ◽  
George E. Georges ◽  
...  
Keyword(s):  
Systemic Sclerosis ◽  
Marrow Transplantation ◽  
Dermal Fibrosis ◽  
Allogeneic Marrow Transplantation ◽  
Allogeneic Marrow

scholarly journals Cytomegalovirus antigen detection in peripheral blood leukocytes after allogeneic marrow transplantation

Blood ◽  
1992 ◽  
Vol 80 (5) ◽  
pp. 1358-1364 ◽  
Author(s):  
M Boeckh ◽  
RA Bowden ◽  
JM Goodrich ◽  
M Pettinger ◽  
JD Meyers
Keyword(s):  
Marrow Transplantation ◽  
Gastrointestinal Disease ◽  
Marrow Transplant ◽  
Cmv Infection ◽  
Culture Methods ◽  
Blood Leukocytes ◽  
Shell Vial ◽  
Allogeneic Marrow Transplantation ◽  
Peripheral Leukocytes ◽  
Allogeneic Marrow

Abstract Detection of cytomegalovirus (CMV) antigenemia was compared with shell vial centrifugation cultures for rapid detection of CMV infection. In a prospective study, 59 CMV seropositive patients were monitored weekly during the first 100 days after allogeneic marrow transplantation for virus excretion from urine, throat, and blood and for antigenemia by direct staining of peripheral leukocytes using an antibody pool directed against pp 65. Antigenemia was present in 21 of 22 patients with culture-proven CMV infection and in 3 of 37 without culture-proven CMV infection (sensitivity 95%, specificity 91%). The median time of onset of antigenemia and shell vial cultures was day 47 and 55 after transplant, respectively (P = .0006). Among patients who developed CMV disease without preceding cultures, antigenemia was detected in all patients with CMV pneumonia (N = 6) and in two of three patients with gastrointestinal disease by a median of 10 and 7 days, respectively, before the onset of disease (P = .0002). Levels of antigenemia were significantly higher in patients with disease or viremia than in patients with excretion from urine or throat (P less than .05). Whether the antigenemia assay is more sensitive than rapid culture methods to focus antiviral prophylaxis in marrow transplant patients must be determined in controlled studies.

A CHRONIC PULMONARY SYNDROME ASSOCIATED WITH GRAFT-VERSUS-HOST DISEASE AFTER ALLOGENEIC MARROW TRANSPLANTATION

1992 ◽  
Vol 54 (6) ◽  
pp. 1002-1007 ◽  
Author(s):  
ANTHONY P. SCHWARER ◽  
J. MICHAEL B. HUGHES ◽  
BEATRICE TROTMAN-DICKENSON ◽  
THOMAS KRAUSZ ◽  
JOHN M. GOLDMAN
Keyword(s):  
Graft Versus Host Disease ◽  
Marrow Transplantation ◽  
Host Disease ◽  
Graft Versus Host ◽  
Allogeneic Marrow Transplantation ◽  
Allogeneic Marrow

Allogeneic marrow transplantation for patients with acute non-lymphoblastic leukemia in second remission

1982 ◽  
Vol 6 (3) ◽  
pp. 395-399 ◽  
Author(s):  
C. Dean Buckner ◽  
Reginald A. Clift ◽  
E. Donnall Thomas ◽  
Jean E. Sanders ◽  
Robert Hackman ◽  
...  
Keyword(s):  
Marrow Transplantation ◽  
Lymphoblastic Leukemia ◽  
Allogeneic Marrow Transplantation ◽  
Allogeneic Marrow

CYTOMEGALOVIRUS PNEUMONITIS AFTER ALLOGENEIC MARROW TRANSPLANTATION

The Lancet ◽  
1987 ◽  
Vol 330 (8553) ◽  
pp. 286-287
Author(s):  
MalcolmK. Brenner ◽  
PaulD. Griffiths ◽  
H.Grant Prentice
Keyword(s):  
Marrow Transplantation ◽  
Allogeneic Marrow Transplantation ◽  
Allogeneic Marrow
Sign in / Sign up

Export Citation Format

Share Document